FGAM
IRD

Financial Gravity Asset Management’s Opus Genetics IRD Stock Holding History

Financial Gravity Asset Management’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$16.3K Buy
+16,555
New +$18.5K ﹤0.01% 515

Other funds holding IRD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Financial Gravity Asset Management's IRD Position: Q1 2025 in Review

Financial Gravity Asset Management opened a new position in Opus Genetics (IRD) in Q1 2025: 16,555 shares worth $16.3K. The stake represents ﹤0.01% of the portfolio and ranks #515 among its holdings.

46 funds tracked by Wall St. Rank hold IRD as of Q1 2025.

  • Financial Gravity Asset Management held 16,555 shares of Opus Genetics worth $16.3K as of Q1 2025.
  • Opus Genetics was a new Financial Gravity Asset Management position in Q1 2025.
  • Opus Genetics made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q1 2025, its #515 holding.
  • 46 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2025.

Based on Financial Gravity Asset Management's 13F filing for Q1 2025, filed 30 Apr 2025.